Almac to Improve Label Approval Process in Clinical Trials
Key Features
The Label Approval System (LAS) has a number of key features that will enhance the overall label approval process allowing the seamless coordination of approvals among multiple approvers.
· Label proofs are automatically sent to predefined user groups
· Users have instant visibility to the status of all label approval tasks
· Automatic email notifications are sent to designated approvers when labels are available
· Identify bottlenecks in the clinical trial label approval process for future improvements.
· Online pdf mark-up brava reader tool to clearly specify changes to label design
· Automatic notification of ‘late’ tasks
· Generate multiple reports
- Current Status Reports – “What labels are with Almac & affiliates and for how long?”
- History Reports – “Who did what in a specific time period”
- Label Lifecycle Reports – “How long did the design, approval, changes take per label?”
Paul O’Connor, Vice President of Quality, Almac Clinical Services commenting on the launch of the new system said ‘ I am delighted to announce the launch of our new Label Approval System – we have invested significantly in the development of this new system which is the latest in a series of process improvements to remove bottlenecks in the clinical supply chain.’
This latest launch also coincides with the launch of a new web based Shipping Temperature Electronic Monitoring System – stems.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025